News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Major Singaporean and Hong Kong investors bet on ASX healthcare’s upside
Health & Biotech
Island completes dosing in phase 2b arm of mosquito-borne dengue trial
Health Check: With a US military win, Bio-Gene declares germ warfare on mosquitos, ticks and bed bugs
News
Closing Bell: Iron ore miners hammered, but Trump’s Canada tariffs boost uranium stocks
Health & Biotech
Island completes phase 2b enrolments in dengue fever trial
Stockhead TV
Road to 2025: Clinical trials hit fever pitch for Island Pharmaceuticals
Long Shortz
Long Shortz with Island Pharmaceuticals: Phase 2b trial into dengue fever kicks off
Health & Biotech
Health Check: Which stock just dumped 19% on earnings downgrade?
Health & Biotech
Island Pharmaceuticals starts phase 2b dengue trial
Long Shortz
Long Shortz with Island Pharmaceuticals: Trial success with dengue fever drug
News
ASX Lunch Wrap: ASX a sea of green after ceasefire; Island Pharma up 30pc on trial results
Health & Biotech
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Health & Biotech
Health Check: Chinese consumer market is a thing of beauty, says EZZ Life Sciences
Health & Biotech
Health Check: Mayne Pharma and Acrux are on a drug expansion drive, generically speaking
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
Health & Biotech
Biocurious: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
Health & Biotech
